Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound Closure

Sponsor
Marmara University (Other)
Overall Status
Completed
CT.gov ID
NCT02534415
Collaborator
(none)
36
3
24

Study Details

Study Description

Brief Summary

Aim of the study is to assess the therapeutic effects of topical hyaluronic-acid use on secondary wound healing of the free gingival graft donor site. The hypothesis of this study is that topical hyaluronic-acid gel has positive effects on secondary wound healing of free gingival graft donor site by reducing pain, burning sensation, and accelerating the healing.

Condition or Disease Intervention/Treatment Phase
  • Drug: Periodontal dressing material
  • Drug: 0.2% Hyaluronic acid gel
  • Drug: 0.8% Hyaluronic acid gel
Phase 4

Detailed Description

The objective of the randomized, single blind, controlled and parallel clinical trial was to assess therapeutic effects of topical hyaluronic-acid on secondary wound healing of free gingival graft donor site.

Primary outcome variables that pain and burning sensation changes were assessed at 3, 7, 14, 21 days after surgery by the examiner. Pain and burning sensation were assessed by patients using the VAS, score 0 indicate no pain or burning sensation, score 10 indicate severe pain or burning sensation. Secondary outcome variables included color match, consistency and epithelization of the wound area. These parameters were assessed by the same examiner at 3, 7, 14, 21 and 42 days after surgery. Color of the palatal mucosa was assessed by comparing it to that of the adjacent and opposite site using the VAS. Score 0 indicate no color match and score 10 indicate very good color match. Consistency of the palatal mucosa was assessed with a blunt instrumentation and scored as soft or firm. Epithelialization was scored clinically as none, partial or complete.

Sample size has been estimated in 12 subjects per treatment groups. Random allocation of the treatment sites to test and control groups will be performed using a computerized selection of random numbers for allocation of the study groups.

Clinical images obtained at baseline, 3, 7, 14, 21 and 42 days after surgery from each treatment site.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound Closure
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Jul 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Periodontal dressing material

Palatal wound area was covered with periodontal dressing material at baseline and 3rd day

Drug: Periodontal dressing material
Procedure:Palatal wound area was covered with periodontal dressing material at baseline and 3rd day
Other Names:
  • Peripac®
  • Experimental: 0.2% Hyaluronic acid gel

    0.2% topical hyaluronic-acid gel was applied to palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day

    Drug: 0.2% Hyaluronic acid gel
    0.2% topical hyaluronic-acid gel was applied to palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day
    Other Names:
  • Gengigel
  • Experimental: 0.8% Hyaluronic acid gel

    0.8% topical hyaluronic-acid gel was applied palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day

    Drug: 0.8% Hyaluronic acid gel
    0.8% topical hyaluronic-acid gel was applied palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day
    Other Names:
  • Gengigel
  • Outcome Measures

    Primary Outcome Measures

    1. Pain [21 days]

      Using a visual analog scale (0: No pain, 10: Severe pain)

    Secondary Outcome Measures

    1. Color match [42 days]

      Using a visual analog scale (0: No color match, 10: Good color match) (Adjacent and opposite site)

    2. Consistency [42 days]

      Soft/firm

    3. Epithelialisation [42 days]

      None/partial/complete

    4. Burning Sensation [21 days]

      Using a visual analog scale (0: No burning sensation, 10: Severe burning sensation)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Good general health

    • No periodontal surgical treatment in the previous 6 months on the involved sites

    Exclusion Criteria:
    • Smoking

    • Patients with a pregnancy or lactation period

    • Self-reported history of antibiotic medication within three months

    • Absence of tooth in the area of donor site

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Marmara University

    Investigators

    • Study Director: Bahar Kuru, Prof. Dr., Marmara University, Faculty of Denistry, Department of Periodontology
    • Study Chair: Başak Doğan, Prof. Dr., Marmara University, Faculty of Denistry, Department of Periodontology
    • Principal Investigator: Hatice Selin Yıldırım, Dr., Marmara University, Faculty of Denistry, Department of Periodontology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marmara University
    ClinicalTrials.gov Identifier:
    NCT02534415
    Other Study ID Numbers:
    • YU-351
    First Posted:
    Aug 27, 2015
    Last Update Posted:
    Aug 27, 2015
    Last Verified:
    Aug 1, 2015
    Keywords provided by Marmara University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 27, 2015